Development of a Mass Spectrometry Based Pharmacokinetic (PK) Assay for the Measurement of RLIP76 Protein and Proteoliposome in Human Serum

Home > Science Hub > Development of a Mass Spectrometry Based Pharmacokinetic (PK) Assay for the Measurement of RLIP76 Protein and Proteoliposome in Human Serum
Back to the list

June 16, 2014

Laura McIntosh¹, Pierre-André Chavaillaz², Lorella Di Donato¹, Elizabeth Leffel², Louiza Mahrouche¹, Marija Mentinova¹, Michael Schirm¹, Henry Hebel² ¹Caprion Proteome Inc; ²Terapio Corporation.

Development of a Mass Spectrometry Based Pharmacokinetic (PK) Assay for the Measurement of RLIP76 Protein and Proteoliposome in Human Serum, AAPS 2014

Development of a Mass Spectrometry Based Pharmacokinetic (PK) Assay for the Measurement of RLIP76 Protein and Proteoliposome in Human Serum

Download poster

You might also be interested by

Posters

Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?

November 10, 2025

Proteomics/Mass Spectrometry

More info

Web News

CellCarta Expands Proteomics Offering with Olink® Reveal Assay

August 6, 2025

Proteomics/Mass Spectrometry

More info

Brochures & Infographics

Supporting Your Targeted Protein Degradation Strategies

April 1, 2025

Proteomics/Mass Spectrometry

More info

Web News

CellCarta Joins Olink™ Certified Service Provider Network in China

February 13, 2025

Proteomics/Mass Spectrometry

More info